Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat7
SCLP Share
Trades65
SCLP
Live RNS
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
SCLP Company
Research
SCLP Company
Timeline
Share Price Information for Scancell Holdings (SCLP)
Last checked at -
Last checked at 
Intraday Scancell Holdings Share Chart
Scancell Holdings News
IN BRIEF: Scancell says needs more time to publish annual results
Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says auditor request additional time to complete standard audit o...
IN BRIEF: Oxford Technology 2 VCT asset value hurt by AIM share falls
Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value of OT1 shares falls by 16%...
Scancell celebrates "positive" clinical trial data for cancer vaccine
(Alliance News) - Scancell Holdings PLC shares surged on Tuesday after the company announced positive results from the phase 2 clinical trial of its S...
Scancell appoints healthcare finance veteran as new CFO
(Sharecast News) - Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, ef...
IN BRIEF: Scancell appoints Prenetics' Sath Nirmalananthan as new CFO
Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Hires Sath Nirmalananthan to be chief financial officer, starting...
AIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trial
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Scancell shares jump on trial expansion for Modi-1 vaccine
(Alliance News) - Scancell Holdings PLC on Monday said it has expanded its Modi-1 trial for the use of checkpoint inhibitors on cancer patients.
Follow the stocks
